Terms: = Leukemia AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E
7152 results:
1. Acute Myeloid leukemia with Myelodysplasia - Related Changes after Isolated Myeloid Sarcoma.
Li X; Yin J; Li L
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747915
[TBL] [Abstract] [Full Text] [Related]
2. Gene Expression and DNA Methylation Profiling Suggest Potential Biomarkers for Azacitidine Resistance in Myelodysplastic Syndrome.
Kim DY; Shin DY; Oh S; Kim I; Kim EJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731939
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical significance of IL-18 and IL-18-binding protein in bone marrow of patients with myelodysplastic syndrome].
Wang T; Ran NY; Chen QL; Liu DL; Zang MT; Li NB; He X; Guan J; Fu R; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):284-289. PubMed ID: 38716601
[No Abstract] [Full Text] [Related]
4. Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/mds: a multicenter retrospective study.
Chen W; Huang J; Zhao Y; Huang L; Yuan Z; Gu M; Xu X; Shi J; Luo Y; Yu J; Lai X; Liu L; Fu H; Bao C; Huang X; Zheng Z; Huang H; Hu X; Zhao Y
J Transl Med; 2024 Apr; 22(1):410. PubMed ID: 38689269
[TBL] [Abstract] [Full Text] [Related]
5. Batimastat Induces Cytotoxic and Cytostatic Effects in In Vitro Models of Hematological Tumors.
Alves R; Pires A; Jorge J; Balça-Silva J; Gonçalves AC; Sarmento-Ribeiro AB
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674139
[TBL] [Abstract] [Full Text] [Related]
6. Myelodysplastic Neoplasms (mds): The Current and Future Treatment Landscape.
Karel D; Valburg C; Woddor N; Nava VE; Aggarwal A
Curr Oncol; 2024 Apr; 31(4):1971-1993. PubMed ID: 38668051
[TBL] [Abstract] [Full Text] [Related]
7. The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation.
Li Z; Wang J; Deng L; Liu X; Kong F; Zhao Y; Hou Y; Zhou F
Front Immunol; 2024; 15():1382099. PubMed ID: 38665912
[TBL] [Abstract] [Full Text] [Related]
8. Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Tazoe K; Harada N; Makuuchi Y; Kuno M; Takakuwa T; Okamura H; Hirose A; Nakamae M; Nishimoto M; Nakashima Y; Koh H; Hino M; Nakamae H
Ann Hematol; 2024 Jun; 103(6):2059-2072. PubMed ID: 38662207
[TBL] [Abstract] [Full Text] [Related]
9. [Survival and Prognosis of Patients with Acute Myeloid leukemia with Myelodysplasia-Related Changes Transformed from Myelodysplastic Syndrome].
Shang LM; Chen HJ; Liu Y; Cao Y; Li F; Guo YT; Dong WM; Lin Y; Gu WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):347-354. PubMed ID: 38660835
[TBL] [Abstract] [Full Text] [Related]
10. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
11. Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms.
Zeng X; Wang Y; Dai M; Li W; Huang Q; Qin L; Li Y; Yan Y; Xue X; Yi F; Li W; He L; Liu Q; Qi L
J Transl Med; 2024 Apr; 22(1):359. PubMed ID: 38632656
[TBL] [Abstract] [Full Text] [Related]
12. Donor
Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
[TBL] [Abstract] [Full Text] [Related]
13. Role of reactive oxygen species in myelodysplastic syndromes.
Jing Q; Zhou C; Zhang J; Zhang P; Wu Y; Zhou J; Tong X; Li Y; Du J; Wang Y
Cell Mol Biol Lett; 2024 Apr; 29(1):53. PubMed ID: 38616283
[TBL] [Abstract] [Full Text] [Related]
14. Myeloid neoplasms post cytotoxic therapy: epidemiology, pathogenesis outcomes, prognostic factors, and treatment options.
Ma J; Wang Y
Ann Med; 2024 Dec; 56(1):2329132. PubMed ID: 38608646
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Tseng MH; Kuo YY; Yu SC; Liu MC; Yuan CT; Yang YT; Chuang MK; Ko BS; Tang JL; Sun HI; Chuang YK; Tien HF; Hou HA; Chou WC
Blood Cancer J; 2024 Apr; 14(1):57. PubMed ID: 38594285
[TBL] [Abstract] [Full Text] [Related]
16. Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations.
Ng AP; Adams R; Tiong IS; Seymour L; Talaulikar D; Palfreyman E; Enjeti A; Tate C
Pathology; 2024 Jun; 56(4):459-467. PubMed ID: 38580613
[TBL] [Abstract] [Full Text] [Related]
17. Construction and experimental validation of a novel ferroptosis-related gene signature for myelodysplastic syndromes.
Zhu Y; He J; Wei R; Liu J
Immun Inflamm Dis; 2024 Apr; 12(4):e1221. PubMed ID: 38578040
[TBL] [Abstract] [Full Text] [Related]
18. Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms.
Dussiau C; Comont T; Knosp C; Vergnolle I; Bravetti C; Canali A; Houvert A; Largeaud L; Daveaux C; Zaroili L; Friedrich C; Boussaid I; Zalmai L; Almire C; Rauzy O; Willems L; Birsen R; Bouscary D; Fontenay M; Kosmider O; Chapuis N; Vergez F
Leukemia; 2024 May; 38(5):1131-1142. PubMed ID: 38575672
[TBL] [Abstract] [Full Text] [Related]
19. [Study of a patient with Myelodysplastic/myeloproliferative neoplasm with co-morbid neutrophilia and a novel NCOR1::GLYR1 fusion gene].
Lei Y; Zhao X; Zhao H; Cheng Y; Wang S; Li J; Zhu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Apr; 41(4):404-410. PubMed ID: 38565504
[TBL] [Abstract] [Full Text] [Related]
20. Rapid progression from mds to AML with gastric submucosal tumour as an extramedullary infiltration.
Kobayashi K; Umekawa Y
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38565228
[TBL] [Abstract] [Full Text] [Related]
[Next]
